Fresenius Kabi reached a global settlement with Amgen concerning their denosumab biosimilars, allowing launch in the United States in mid-2025 and in Europe later in 2025.
Dollar Tree's net sales for the quarter increased .7% to $5 billion, while same-store net sales increased 2%, driven by a .7% increase in traffic and a 1.3% increase in average ticket.